MEDIKINE

medikine-logo

Medikine is a biotechnology company that specializes in the creation of novel cytokine and growth factor receptor agonists. Medikine’s proprietary compounds mimic the activities of the natural protein agonists, but are much lower in molecular weight and completely unrelated in sequence and structure. It was founded in 2008 and headquartered in Menlo Park, California.

#People #Website #More

MEDIKINE

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2008-01-01

Address:
Menlo Park, California, United States

Country:
United States

Website Url:
http://www.medikine.com

Total Employee:
1+

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS


Current Employees Featured

gianna-m-bosko_image

Gianna M. Bosko
Gianna M. Bosko Chief Administrative Officer, General Counsel, and Secretary @ Medikine
Chief Administrative Officer, General Counsel, and Secretary

michael-c-needels_image

Michael C. Needels
Michael C. Needels Co-Founder, Chief Technology Officer @ Medikine
Co-Founder, Chief Technology Officer
2021-11-01

joseph-leveque_image

Joseph Leveque
Joseph Leveque President, CMO, and Board Member @ Medikine
President, CMO, and Board Member

william-dower_image

William Dower
William Dower Co-Founder and CSO @ Medikine
Co-Founder and CSO

marcos-milla_image

Marcos Milla
Marcos Milla Interim CSO and Board Member @ Medikine
Interim CSO and Board Member

not_available_image

Ronald W. Barrett
Ronald W. Barrett CEO and Chairman of the Board @ Medikine
CEO and Chairman of the Board

Founder


michael-c-needels_image

Michael C. Needels

william-dower_image

William Dower

Official Site Inspections

http://www.medikine.com

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Medikine"

Medikine - Crunchbase Company Profile & Funding

Medikine is a biotechnology company that specializes in the creation of novel cytokine and growth factor receptor agonists. Medikine’s proprietary …See details»

Medikine

Medikine is led by an accomplished team of industry veterans with decades of experience in pioneering drug discovery technology and the clinical development of immuno-oncology …See details»

About — Medikine

Transforming the discovery and development of therapeutics in oncology, autoimmune disorders, and infectious disease. Medikine is employing a versatile drug discovery platform that generates modular cytokine-mimetic …See details»

Team — Medikine

Along the way, we’ve learned important lessons that we’re applying at Medikine today. Joseph Leveque, MD. CEO, President, and Board Member. Read Bio. Marcos Milla, PhD. Chairman …See details»

Medikine 2025 Company Profile: Valuation, Funding

When was Medikine founded? Medikine was founded in 2008. Where is Medikine headquartered? Medikine is headquartered in Menlo Park, CA. What is the …See details»

Medikine, Inc. Information - RocketReach

Medikine’s lead product candidate MDK-703, which is planned to enter clinical trials in 2022, is an Fc-fusion protein containing an IL-7 PEPTIKINE, which emulates the beneficial properties of IL …See details»

Medikine - Org Chart, Teams, Culture & Jobs | The Org

Medikine utilizes a proprietary platform to identify agonists of clinically relevant heterodimeric cytokine receptors for the development of novel therapeutics for immuno-oncology applications in cell therapy and neo-antigen vaccines. …See details»

Medikine, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Jan 23, 2025 Medikine’s lead candidate, MDK-703, currently in a Phase 1 clinical trial in healthy volunteers, is an IL-7 PEPTIKINE fused to an immunoglobulin Fc-domain. ... The statistics for …See details»

Medikine, Inc. Overview | SignalHire Company Profile

Medikine is a biopharmaceutical company with a mission to transform the discovery of oncology, autoimmune disorder, ... Organization Website: medikine.com : Medikine, Inc. industries …See details»

MEDIKINE, INC. - VentureRadar

Medikine is employing a versatile drug discovery platform that generates modular cytokine-mimetic “PEPTIKINES” that are smaller in molecular size than, and structurally unrelated to, …See details»

Medikine - Overview, News & Similar companies | ZoomInfo.com

Oct 4, 2022 Who is Medikine. Medikine, Inc. is a privately held, preclinical-stage biopharmaceutical company utilizing a proprietary platform to identify activators of clinical ly …See details»

Medikine - Crunchbase

Medikine specializes in the creation of novel cytokine and growth factor receptor agonists.See details»

Medikine - Contacts, Employees, Board Members, Advisors & Alumni

Medikine specializes in the creation of novel cytokine and growth factor receptor agonists. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»

Medikine Company Profile - Office Locations, Competitors ... - Craft

Medikine is a biopharmaceutical discovery company that develops cytokine and growth factor receptor agonists. Its technology platform helps to identify agonists of clinically relevant …See details»

Medikine | Lightspeed | Venture Capital

Medikine utilizes a proprietary platform to identify agonists of clinically relevant heterodimeric cytokine receptors for the development of novel therapeutics for immuno-oncology …See details»

Medikine CEO and Key Executive Team | Craft.co

Medikine's Chairman of the Board and Interim CSO is Marcos Milla. Other executives include Michael Needels, Co-founder and Chief Technology Officer; Shelley Chu, Board Member and …See details»

Pipeline — Medikine

Medikine is currently optimizing these unique “cell-targeted” IL-2/15βγc receptor agonists. Dual Agonist Using its unique knowledge of the structure-activity relationships of IL-7 and IL-2 …See details»

Careers - Medikine

To apply, please email [email protected] with your resume and the job title in the subject line of the email. Current Openings. Get in Touch. Up for a challenge with limitless possibilities? We …See details»

Science — Medikine

They are engineered for low immunogenicity, and since they are unrelated in sequence to the natural cytokine, there’s little risk of generating antibodies that neutralize the endogenous …See details»

News — Medikine

Nov 10, 2020 Medikine to Highlight Preclinical Data on its Lead Program MDK-703, an IL-7 Mimetic, at the 2022 Annual Meeting of the American Association for Cancer Research …See details»